TOKYO, May 6, 2024
/PRNewswire/ -- ThinkCyte today announced that it will be
presenting at three major international scientific conferences in
the first week of May and the launch of its updated website. The
company will have a presence at the American Society for Immunology
(AAI) from May 3rd to 7th, the
Association for Research in Vision and Ophthalmology (ARVO) from
May 5th to 9th,
and CYTO 2024 presented by the International Society for
Advancement of Cytometry (ISAC) from May
4th to 8th. The events will showcase
both internal research and development achievements as well as
presentations from VisionSort customers on the application of the
platform to advance research and therapeutic development
efforts.
"A year ago we launched VisionSort and had just been recognized
for technology innovation at CYTO, the premiere international
cytometry meeting," said Janette
Phi, Chief Business Officer at ThinkCyte. "Since then we've
had the privilege of working closely with our innovation-minded
early adopter customers who have been instrumental in pushing the
real-world applications of what this technology can do. The
diversity of presentations this month and the new website reflects
this growth and we look forward to another year of helping our
customers advance cell-based R&D efforts in new and exciting
ways."
Developed with the user experience in mind, the updated site
includes many new features including:
- Streamlined and user-friendly explanations of
Ghost CytometryTM, the core technology inside
VisionSort
- Easier access to VisionSort Resources including
Application Notes, Publications, Posters, and Videos
- More info on VisionSort values for Cell Therapy R&D,
Drug Discovery, & Disease Profiling
- A new Partnering Page for life science technology and
Biopharma companies seeking to accelerate R&D of novel
therapeutics with AI-based approaches.
For more information about ThinkCyte's upcoming events, visit:
https://thinkcyte.com/conferences/https://doi.org/10.1016/j.stemcr.2023.12.001
About ThinkCyte
ThinkCyte, founded in 2016 with offices in Tokyo, Japan and Redwood City, California is a biotechnology
company that develops innovative scientific instruments based on
integrated, multidisciplinary technologies to enable life science
research, diagnostics, and therapeutic development. The company's
flagship product, VisionSort, is the world's first AI-based,
dual-mode fluorescence and morphometric cell sorting platform and
it partners with major global biopharmaceutical companies and
leading academic research institutes to further drive
groundbreaking research. For more information, please visit
www.thinkcyte.com.
To learn more about VisionSort, the commercially available
platform powered by Ghost Cytometry, visit
https://thinkcyte.com/product/ or email contact@thinkcyte.com. To
learn more about research partnerships or other partnering
opportunities with ThinkCyte, visit
https://info.thinkcyte.com/partnership or email
partner@thinkcyte.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/thinkcyte-launches-new-website-and-showcases-visionsorttm-at-global-events-302136843.html
SOURCE ThinkCyte Inc.